Examining the biological features of early breast cancer in Pakistani women
Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population
This study looks at the unique biological features of early breast cancer in Pakistani women to better understand the disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Sex | Female |
| Sponsor | Liaquat University of Medical & Health Sciences Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Jamshoro) |
| Trial ID | NCT06830590 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the molecular characterization of early operable primary breast cancer specifically within the Pakistani population. It aims to analyze the biological characteristics of breast cancer using immunohistochemistry (IHC) techniques. The study will involve women who have a confirmed diagnosis of breast cancer and have not undergone any pre-operative chemotherapy or radiotherapy, ensuring the collection of high-quality tumor samples for analysis.
Who should consider this trial
Good fit: Ideal candidates for this study are women diagnosed with early operable primary breast cancer who have not received any neoadjuvant therapy.
Not a fit: Patients who have undergone pre-operative chemotherapy or radiotherapy will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of breast cancer biology in Pakistani women, leading to improved treatment strategies.
How similar studies have performed: While similar studies have been conducted in other populations, this specific focus on the Pakistani population represents a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women with confirmed diagnosis of breast cancer without history of taking neoadjuvant therapy Good quality tumour samples available for IHC Exclusion Criteria: * patients received pre-operative chemotherapy or radiotherapy
Where this trial is running
Jamshoro
- Binafsha M Syed — Jamshoro, Pakistan (Recruiting)
Study contacts
- Principal investigator: Binafsha Manzoor M Syed, MBBS, PhD — Liaquat University of Medical & Health Sciences, Jamshoro
- Study coordinator: Binafsha Manzoor M Syed, MBBS, PhD
- Email: Binafsha.syed@lumhs.edu.pk
- Phone: +923332749201
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.